References
- 1. TADDEI S, CARACCIO N, VIRDIS A, DARDANO A, VERSARI D, GHIADONI L, et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab. 2003; 88: 3731-3737.
- 2. CANARIS GJ, MANOWITZ NR, MAYOR G, RIDGWAY EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000; 160:526-34.
- 3. UPADYA UB, SUMA MN, SRINATH KM, PRASHANT A, DODDAMANI P, SHILPA SV, et al. Effect of insulin resistance in assessing the clinical outcome of clinical and subclinical hypothyroid patients. Journal of clinical and diagnostic research: JCDR. 2015; 9(2): OC01-. OC04.
- 4. MAZAHERI T, SHARIFI F, KAMALI K. Insulin resistance in hypothyroid patients under Levothyroxine therapy: a comparison between those with and without thyroid autoimmunity. Journal of Diabetes & Metabolic Disorders. 2014; 13(1): 103.
- 5. PEPPA M, KOLIAKI C, NIKOLOPOULOS P, RAPTIS SA. Skeletal muscle insulin resistance in endocrine disease. Journal of Biomedicine and Biotechnology 2010. Article ID 527850.
- 6. SINGH BM, GOSWAMI B, MALLIKA V. Association between insulin resistance and hypothyroidism in females attending a tertiary care hospital. Indian Journal of Clinical Biochemistry. 2010; 25 (2): 141-145.10.1007/s12291-010-0026-x
- 7. CHUBB SA, DAVIS WA, DAVIS TM. Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study. J Clin Endocrinol Metab. 2005; 90: 5317-20.10.1210/jc.2005-0298
- 8. LADENSON PW, SINGER PA, AIN KB, BAGCHI N, BIGOS ST, LEVY EG, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med. 2000; 160: 1573–1575.
- 9. ASVOLD BO, VATTEN LJ, NILSEN TI, BJORO T. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol. 2007; 156: 181-6.
- 10. PEARCE EN, WILSON PW, YANGY Q, VASAN RS, BRAVERMAN LE. Thyroid function and lipid subparticle sizes in patients with short term hypothyroidism and a population-based cohort. J Clin Endocrinol Metab. 2008; 93: 888-94.
- 11. ÇATLI G, ANIK A, ÜNVER TUHAN H, BOBER E, ABACT A. The effect of L-thyroxine treatment on hypothyroid symptom scores and lipid profile in children with subclinical hypothyroidism. J Clin Res Pediatr Endocrinol. 2014; 6: 238-244.
- 12. MUTLU S, PARLAK A, AYDOGAN U, AYDOGDU A, SOYKUT B, AKAY C, et al. The effect of levothyroxine replacement therapy on lipid profile and oxidative stress parameters in patients with subclinical hypothyroid. Archives of pharmacal research. 2013; 1-9.
- 13. BAMASHMOOS SA, AL-NUZAILY MAK, AL-MEERI AM, ALI FHH. Relationship between total homocysteine, total cholesterol and creatinine levels in overt hypothyroid patients. SpringerPlus. 2013; 2: 423.
- 14. DAGRE AG, LEKAKIS JP, PAPAIOANNOU TG, PAPAMICHAEL CM, KOUTRAS DA, STAMATELOPOULOS SF, et al. Arterial stiffness is increased in subjects with hypothyroidism. Int J Cardiol. 2005; 103: 1-6.
- 15. OBRADOVIC M, GLUVIC Z, SUDAR-MILOVANOVIC E, PANIC A, TREBALJEVAC J, BAJIC V, et al. Nitric oxide as a marker for levo-thyroxine therapy in subclinical hypothyroid patients. Curr Vasc Pharmacol. 2016; 14(3): 266-70.10.2174/1570161114666160208143537
- 16. DAGRE AG, LEKAKIS JP, PROTOGRON AD. Abnormal endothelial function in female patients with hypothyroidism and borderline thyroid function. Int J Cardiol. 2007; 114: 332–338.
- 17. QUESADA A, SAINZ J, WANGSTEEN R, RODRIGUEZ-GOMEZ I, VARGAS F, OSUNA A. Nitric oxide synthase activity in hyperthyroid and hypothyroid rats. European Journal of Endocrinology. 2002; 147(1): 117-122.
- 18. 18. BRADLEY SE, STEPHAN F, COELHO JB, REVILLE P. The thyroid and the kidney. Kidney international. 1974; 6(5): 346-365.10.1038/ki.1974.119
- 19. KLEIN I, OJAMAA K. Thyroid hormone and the cardiovascular system. New England Journal of Medicine. 2001; 344(7): 501-509.
- 20. DANZI S, KLEIN I. Thyroid hormone and blood pressure regulation. Curr Hypertens Rep. 2003; 5:513-20.10.1007/s11906-003-0060-7
- 21. BASKIN HJ, COBIN RH, DUICK DS, GHARIB H, GUTTLER RB, KAPLAN MM, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 2002; 8:457-469.
- 22. RAMSEY MW, GOODFELLOW J, JONES CJH, LUDDINTON LA, LEWIS MJ, HENDERSON AH. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation. 1995; 92: 3212-3219.10.1161/01.CIR.92.11.3212
- 23. HUSSEIN WI, GREEN R, JACOBSEN DW, FAMAN C. Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism. Annals of internal medicine. 1999; 131(5): 348-351.
- 24. FICHTLSCHERER S, ROSENBERGER G, WALTER DH, BREUER S, DIMMELER S, ZEIHER AM. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation. 2000; 102: 1000-1006.10.1161/01.CIR.102.9.1000
- 25. SELLITTI DF, DENISSON D, AKAMIZU T, DOI SQ, KOHN LD, KOSHIYAMA H. Thyrotropin regulation of cyclic adenosine monophosphate production in human coronary artery smooth muscle cells. Thyroid. 2000; 10: 219-225.
- 26. PAPAIOANNOU GI, LAGASSE M, MATHER JF, THOMPSON PD. Treating hypothyroidism improves endothelial function. Metabolism. 2004; 53: 278-9.
- 27. CAPPOLA AR, LADENSON PW. Hypothyroidism and atherosclerosis. The Journal of Clinical Endocrinology & Metabolism. 2003; 88(6): 2438-2444.10.1210/jc.2003-030398
- 28. NESS GC, CHAMBERS CM. Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity, Proc. Soc. Exp. Biol. Med. 2000; 224: 8-19.
- 29. SHIN DJ, OSBORNE TF. Thyroid hormone regulation and cholesterol metabolism are connected through Sterol Regulatory Element Binding Protein-2 (SREBP-2). J Biol Chem. 2003; 278: 34114-8.
- 30. HUUSKONEN J, VISHNU M, PULLINGER CR, FIELDING PE, FIELDING CJ. Regulation of ATP-binding cassette transporter A1 transcription by thyroid hormone receptor. Biochem. 2004; 43(6): 1626-1632.
- 31. GOLDSTEIN JL, DEBOSE-BOYD RA, BROWN MS. Protein sensors for membrane sterols. Cell. 2006; 124(1): 35-46.
- 32. HASHIMOTO K, COHEN RN, YAMADA M, MARKAN KR, MONDEN T, SATOH T, et al. Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model. Journal of Biological Chemistry. 2006; 281(1): 295-302.
- 33. LOPEZ D, ABISAMBRA SOCARRAS JF, BEDI M, NESS GC. Activation of the hepatic LDL receptor 703 promoter by thyroid hormone. Biochim Biophys Acta. 2007; 1771: 1216-1225.
- 34. JIN T, TENG X. Update on Lipid Metabolism and Thyroid Disorders. J Endocrinol Diabetes Obes. 2014; 2(3): 1043.
- 35. BANSAL SK, YADAV R. A Study of the Extended Lipid Profile including Oxidized LDL, Small Dense LDL, Lipoprotein (a) and Apolipoproteins in the Assessment of Cardiovascular Risk in Hypothyroid Patients. Journal of clinical and diagnostic research: JCDR. 2016; 10(6): BC04.
- 36. JUNG CH, SUNG KC, SHIN HS, RHEE EJ, LEE WY, KIM BS, et al. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea. Korean J Intern Med. 2003; 18: 146-53.10.3904/kjim.2003.18.3.146
- 37. DUMAN D, SAHIN S, ESERTAS K, DEMIRTUNC R. Simvastatin improves endothelial function in patents with subclinical hypothyroidism. Heart Vessels. 2007; 22: 88-93.10.1007/s00380-006-0950-0
- 38. RIZOS C, ELISAF MS, LIBEROPOULOS EN. Effects of thyroid dysfunction on lipid profile. Open Cardiovascular Medicine Journal. 2011; 5: 76-84.
- 39. AL-TONSI AA, ABDEL-GAYOUM AA, SAAD M. The secondary dyslipidemia and deranged serum phosphate concentration in thyroid disorders. Exp Mol Pathol. 2004; 76: 182-7.
- 40. TEIXEIRA Pde F, REUTERS VS, FERREIRA MM, ALMEIDA CP, REIS FAA, BUESCU A, et al. Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure. Transl Res. 2008; 151: 224-31.
- 41. MARWAHA R, TANDON N, GARG M, KANWAR R, SASTRY A, NARANG A, et al. Dyslipidemia in subclinical hypothyroidism in an Indian population. Clin Biochem. 2011; 44(14-15): 1214-1217.10.1016/j.clinbiochem.2011.07.003
- 42. BOELAERT K, FRANKLYN J. Thyroid hormone in health and disease. Journal of Endocrinology. 2005; 187(1): 1-15.
- 43. RIFAI N, WARNICK GR. Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors. In: Burtis CA, Ashwood ER, Bruns DE, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th ed. Philadelphia, Pa: Elsevier Saunders; 2006: 903–982.
- 44. MARATOU E, HADJIDAKIS DJ, KOLLIAS A, TSEGKA K, PEPPA M, ALEVIZAKI M, et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol. 2009; 160: 785-90.